[1]
M. Vaitkus, “INDACATEROL - THE NEWEST AND THE FIRST ONCE-DAILY-B2-AGONIST FOR THE TREATMENT OF COPD”, PIA, vol. 10, no. 1, pp. 50-54, May 2012.